These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20938993)

  • 1. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
    Kakkar V; Singh S; Singla D; Kaur IP
    Mol Nutr Food Res; 2011 Mar; 55(3):495-503. PubMed ID: 20938993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats.
    Kakkar V; Singh S; Singla D; Sahwney S; Chauhan AS; Singh G; Kaur IP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3427-31. PubMed ID: 21111692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
    Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
    Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
    Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
    Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
    Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.
    Anwar M; Ahmad I; Warsi MH; Mohapatra S; Ahmad N; Akhter S; Ali A; Ahmad FJ
    Eur J Pharm Biopharm; 2015 Oct; 96():162-72. PubMed ID: 26241925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability.
    Wu X; Xu J; Huang X; Wen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):15-23. PubMed ID: 20738181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J; Tabbakhian M; Mohammadi MY
    J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
    Khalil NM; do Nascimento TC; Casa DM; Dalmolin LF; de Mattos AC; Hoss I; Romano MA; Mainardes RM
    Colloids Surf B Biointerfaces; 2013 Jan; 101():353-60. PubMed ID: 23010041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
    Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
    Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.